Tradestie Institutional Equity Comparison Engine
BUDA vs EXOZ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BUDA Overall Edge
BUDA Captures Institutional Edge (2โ1 Pillars ยท 1โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BUDA (BUDA) driven by superior Momentum & Technical, Options & Structure while EXOZ counters with relative strength in Growth & Margin. Fundamentally, BUDA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus EXOZ at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BUDA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EXOZ sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BUDA N/M vs EXOZ N/M Fwd P/E
Growth & Margin Winner
EXOZ
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
BUDA
1Y -34.6% vs -81.0% ยท 52W Pos 1% vs 1%
Options & Structure Winner
BUDA
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
BUDA
US Equity
BUDA
Institutional Equity
$5.30
-0.19% 1D
Market Cap
N/A
1M Return
-20.9%
1Y Return
-34.65%
Forward P/E
N/M
Unified AI Score
34.2 / 100
SELL
Tech 35.0
Fund 42.0
Flow 50.0
Mom 55.0
EXOZ
NASDAQ
eXoZymes Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$2.90
-14.05% 1D
Market Cap
$31.9M
1M Return
-25.51%
1Y Return
-80.96%
Forward P/E
N/M
Unified AI Score
42.3 / 100
HOLD
Tech 25.0
Fund 51.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BUDA -34.65%
EXOZ -80.96%
Spread: +35.34 pp (BUDA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BUDA TTM Op. Margin: N/A
EXOZ TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BUDA vs EXOZ. Trailing 12-month operating profitability (BUDA N/A vs EXOZ 0.0%) and valuation multiples (BUDA N/M vs EXOZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BUDA | EXOZ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $31.9M | Larger Scale | EXOZ |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | EXOZ |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | EXOZ |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | EXOZ |
| Return on Equity (ROE) Capital Efficiency | N/A | -187.2% | Higher ROE | EXOZ |
| 52-Week Range Position Momentum | 1% ($5โ$12) | 1% ($3โ$17) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | -0.03ฮฒ ยท 71% Vol | 1.00ฮฒ ยท 109% Vol | Lower Realized Risk | BUDA |
| Unified Institutional Score Composite Signal | 34.2 / 100 (SELL) | 42.3 / 100 (HOLD) | Higher Composite | EXOZ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BUDA vs EXOZ Buy Guide
BUDA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
EXOZ
BREAKDOWN
57d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BUDA nor EXOZ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.